HkRoidsTirzepatide
Ordered Tirzepatide from HkRoids? Mail in a sample (US only) and let us test it for free.
Test my supplyHkRoids Tirzepatide is pulled down by repeated purity misses and a sharp recent failure: an April 2026 COA reported 0 mg and 0% purity for a 60 mg vial. Earlier results are mixed, with several no-label or missing-batch entries.
Wayback captures tie HkRoids to a China-linked raw-steroid exporter, while current records do not substantiate a US operating entity. The report follows the rep network, payment rails, defunct sister domains, and a Tirzepatide identity dispute.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including HkRoids rows.
Cancel anytime
Ordered Tirzepatide from HkRoids? Mail in a sample (US only) and let us test it for free.
Test my supplyAbout HkRoids test results from Finnrick
HkRoids is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 11 peptides and 80 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible HkRoids peptides in this dataset are BPC-157 (10 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 80 recent tests.
Ordered Tirzepatide from HkRoids? Mail in a sample (US only) and let us test it for free.
Test my supply